Gerges RIZKALLAH

مدرّس

مَدْرَسَة التَّحْضِير المَخْبَرِيّ الطِّبّي
كُلِّيّة الصَّيْدَلة

+961 (1) 421 000 gerges.rizkallah1@usj.edu.lb


المنشورات والمداخلات

§  Septembre 2019 : Rizkallah Gerges, Renaud Mahieux, Hélène Dutartre. ‘Clinical Approaches of HIV-1/HTLV-1 Co-infection Still Keep their Mysteries?’’ Journal of infectiology, August 30, 2019 §  Décembre 2018 : Rizkallah Gerges and Hélène Dutartre. ‘’A continuing journey for HTLV-1 antiviral development?’’ EC microbiology, December 28, 2018 §  Octobre 2017 : Rizkallah Gerges, Chloé Journo, Renaud Mahieux, and Hélène Dutartre. “How Does Susceptibility to HTLV-1 Infection Varies with the Maturation State of Dendritic Cells?” Future Virology, October 11, 2017. doi:10.2217/fvl-2017-0075. §  Octobre 2017 : Teruel, Élodie, Gerges Rizkallah, Chloé Journo, and Hélène Dutartre. “[The actin cytoskeleton goes retroviral].” Medecine Sciences: M/S 33, no. 10 (October 2017): 839–42. doi:10.1051/medsci/20173310009. §  Avril 2017 : Rizkallah, Gergès, Sandrine Alais, Nicolas Futsch, Yuetsu Tanaka, Chloé Journo, Renaud Mahieux, and Hélène Dutartre. “Dendritic Cell Maturation, but Not Type I Interferon Exposure, Restricts Infection by HTLV-1, and Viral Transmission to T-Cells.” PLoS Pathogens 13, no. 4 (April 2017): e1006353. doi:10.1371/journal.ppat.1006353. §  Juillet 2015 : Gerges, Renaud Mahieux, and Hélène Dutartre. “[Intercellular transmission of HTLV-1: not all mechanisms have been revealed].” Medecine Sciences: M/S 31, no. 6–7 (July 2015): 629–37. doi:10.1051/medsci/20153106016.